Abbott Laboratories has denied reports that it is pursuing a $25 billion bid to buy St. Jude Medical Inc. . Shares of St. Jude traded sharply higher in premarket trade following a Financial Times report, citing anonymous sources. St. Jude's shares were up 5% in premarket trade, putting them on track to open around $73. Those of Abbott were up 3.2%.
Copyright © 2015 MarketWatch, Inc.
Continue Reading Below